$139.77
0.68 (-0.48%)
Last updated: Apr 16, 2026 01:04
Fundamentals Overview
Gilead Sciences, Inc. is in the middle of its 52-week range with moderate valuation, trading relatively flat today.
Valuation moderate
Intrinsic value (DCF)
+17.3% upside vs price
Profitability
Risk (Beta)
0.4 — lower vol
Earnings & growth
BullzEye Analysis
Our composite tilts Buy on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
DCF +17.3% upside vs price · Analyst grade: B+ · Sentiment improving (2 upgrades) · 3M vs S&P 500: +13.3% · 3M vs Healthcare sector: +20.1%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: B+. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 14, Neutral: 1, Outperform: 1, Overweight: 10, Sector Outperform: 1, Sector Perform: 3.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $163.96; current price is $139.77. That’s a +17.3% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 20.58 |
| DCF value (model) | $163.96 (17.3% upside) |
| PEG (TTM) | 0.01 |
| P/B (TTM) | 7.68 |
| P/S (TTM) | 5.89 |
| P/FCF (TTM) | 18.35 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 1.68 |
| Quick Ratio (TTM) | 1.31 |
| Cash Ratio (TTM) | 0.64 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 28.9% |
| Gross margin (TTM) | 80.8% |
| Operating margin (TTM) | 37.37% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for GILD.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Morgan Stanley | maintain | Overweight | Overweight | 2026-04-10 |
| Needham | maintain | Buy | Buy | 2026-02-23 |
| Scotiabank | maintain | Sector Outperform | Sector Outperform | 2026-02-11 |
| RBC Capital | maintain | Sector Perform | Sector Perform | 2026-02-11 |
| Needham | maintain | Buy | Buy | 2026-02-11 |
| Wells Fargo | maintain | Overweight | Overweight | 2026-02-11 |
| Cantor Fitzgerald | maintain | Overweight | Overweight | 2026-02-11 |
| Truist Securities | maintain | Buy | Buy | 2026-02-11 |
| Truist Securities | maintain | Buy | Buy | 2026-01-27 |
| Citigroup | maintain | Buy | Buy | 2026-01-27 |
| UBS | maintain | Buy | Buy | 2026-01-26 |
| Morgan Stanley | maintain | Overweight | Overweight | 2026-01-13 |
| Citigroup | maintain | Buy | Buy | 2026-01-07 |
| Morgan Stanley | maintain | Overweight | Overweight | 2025-12-12 |
| Wells Fargo | maintain | Overweight | Overweight | 2025-12-10 |
| Needham | maintain | Buy | Buy | 2025-11-13 |
| Truist Securities | maintain | Buy | Buy | 2025-11-03 |
| RBC Capital | maintain | Sector Perform | Sector Perform | 2025-10-31 |
| Needham | maintain | Buy | Buy | 2025-10-31 |
| JP Morgan | maintain | Overweight | Overweight | 2025-10-31 |
| Cantor Fitzgerald | maintain | Overweight | Overweight | 2025-10-31 |
| Wells Fargo | maintain | Overweight | Overweight | 2025-10-31 |
| TD Cowen | maintain | Buy | Buy | 2025-10-23 |
| Citigroup | maintain | Buy | Buy | 2025-10-08 |
| JP Morgan | maintain | Overweight | Overweight | 2025-09-16 |
| UBS | maintain | Neutral | Neutral | 2025-08-08 |
| Truist Securities | upgrade | Hold | Buy | 2025-08-08 |
| RBC Capital | maintain | Sector Perform | Sector Perform | 2025-08-08 |
| BMO Capital | maintain | Outperform | Outperform | 2025-08-08 |
| Needham | upgrade | Hold | Buy | 2025-07-25 |